Malignant counterpart of myeloid dendritic cell (DC) belonging to acute myelogenous leukemia (AML) exhibits a dichotomous immunoregulatory potential

scientific article

Malignant counterpart of myeloid dendritic cell (DC) belonging to acute myelogenous leukemia (AML) exhibits a dichotomous immunoregulatory potential is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1189/JLB.0602267
P698PubMed publication ID12525565

P2093author name stringKanako Shimizu
Shin-ichiro Fujii
Fumio Kawano
Fujimoto Koji
P433issue1
P921main subjectleukemiaQ29496
dendritic cellQ506253
P304page(s)82-90
P577publication date2003-01-01
P1433published inJournal of Leukocyte BiologyQ1524048
P1476titleMalignant counterpart of myeloid dendritic cell (DC) belonging to acute myelogenous leukemia (AML) exhibits a dichotomous immunoregulatory potential
P478volume73

Reverse relations

cites work (P2860)
Q79495901Acute differentiated dendritic cell leukemia: a variant form of pediatric acute myeloid leukemia with MLL translocation
Q53062250CD1c(+) myeloid dendritic cells in myeloid neoplasia.
Q44761444Chemotherapy plus G-CSF mobilized peripheral blood stem cell harvests from acute myeloid leukaemia patients contain large amounts of polyclonal myeloid linnegCD11cpos dendritic precursor cells
Q26864603Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies
Q41688469Dendritic cells in bone marrow at diagnosis and after chemotherapy in adult patients with acute myeloid leukaemia
Q53208374Histiocytic differentiation in acute monocytic leukemia.
Q41326662Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells
Q26852652The characterization and role of leukemia cell-derived dendritic cells in immunotherapy for leukemic diseases

Search more.